Date Action Amount Person Type
Apr 15, 2024 Buy 10 000 Mazabraud Yann Restricted Stock Units
Apr 15, 2024 Buy 8 905 Mazabraud Yann Restricted Stock Units
Apr 15, 2024 Sell 6 874 Mazabraud Yann Restricted Stock Units
Apr 14, 2024 Sell 10 375 Mazabraud Yann Common Stock
Apr 14, 2024 Sell 10 375 Mazabraud Yann Restricted Stock Units
Apr 02, 2024 Sell 368 German Christopher Paul Common Stock
Mar 21, 2024 Sell 18 235 Shulman Joseph Common Stock
Mar 20, 2024 Sell 1 163 German Christopher Paul Restricted Stock Units
Mar 20, 2024 Buy 1 163 German Christopher Paul Common Stock
Mar 20, 2024 Sell 9 169 Lee Jennifer Kayden Common Stock
Mar 20, 2024 Sell 9 066 Lee Jennifer Kayden Common Stock
Mar 19, 2024 Sell 15 515 Smith Hunter C Common Stock
Mar 19, 2024 Sell 15 515 Shulman Joseph Common Stock
Mar 19, 2024 Sell 45 494 Meeker David P Common Stock
Mar 19, 2024 Sell 16 000 Mazabraud Yann Common Stock
Mar 19, 2024 Sell 15 515 Lee Jennifer Kayden Common Stock
Mar 19, 2024 Sell 15 515 Cramer Pamela J. Common Stock
Feb 16, 2024 Buy 259 000 Meeker David P Stock Option (Right to Buy)
Feb 16, 2024 Buy 99 000 Meeker David P Common Stock
Feb 16, 2024 Buy 85 000 Meeker David P Restricted Stock Units
Feb 16, 2024 Buy 67 000 Mazabraud Yann Stock Option (Right to Buy)
Feb 16, 2024 Buy 33 750 Mazabraud Yann Common Stock
Feb 16, 2024 Buy 22 000 Mazabraud Yann Restricted Stock Units
Feb 16, 2024 Buy 7 225 German Christopher Paul Restricted Stock Units
Feb 16, 2024 Buy 5 400 German Christopher Paul Stock Option (Right to Buy)
Feb 16, 2024 Buy 33 750 Smith Hunter C Common Stock
Feb 16, 2024 Buy 80 400 Smith Hunter C Stock Option (Right to Buy)
Feb 16, 2024 Buy 26 400 Smith Hunter C Restricted Stock Units
Feb 16, 2024 Buy 50 250 Shulman Joseph Stock Option (Right to Buy)
Feb 16, 2024 Buy 33 750 Shulman Joseph Common Stock
Feb 16, 2024 Buy 16 500 Shulman Joseph Restricted Stock Units
Feb 16, 2024 Buy 67 000 Lee Jennifer Kayden Stock Option (Right to Buy)
Feb 16, 2024 Buy 33 750 Lee Jennifer Kayden Common Stock
Feb 16, 2024 Buy 22 000 Lee Jennifer Kayden Restricted Stock Units
Feb 14, 2024 Sell 1 089 Shulman Joseph Common Stock
Feb 13, 2024 Sell 1 865 Shulman Joseph Common Stock
Feb 13, 2024 Sell 709 Smith Hunter C Common Stock
Feb 13, 2024 Sell 957 Mazabraud Yann Common Stock
Feb 13, 2024 Sell 615 Lee Jennifer Kayden Common Stock
Feb 13, 2024 Sell 473 Shulman Joseph Common Stock
Feb 12, 2024 Sell 1 209 Smith Hunter C Common Stock
Feb 12, 2024 Sell 1 594 Mazabraud Yann Common Stock
Feb 12, 2024 Sell 1 023 Lee Jennifer Kayden Common Stock
Feb 12, 2024 Sell 791 Shulman Joseph Common Stock
Feb 12, 2024 Sell 696 Cramer Pamela J. Common Stock
Feb 11, 2024 Buy 2 344 Smith Hunter C Common Stock
Feb 11, 2024 Sell 2 344 Smith Hunter C Restricted Stock Units
Feb 11, 2024 Buy 2 031 Mazabraud Yann Common Stock
Feb 11, 2024 Sell 2 031 Mazabraud Yann Restricted Stock Units
Feb 11, 2024 Buy 2 031 Lee Jennifer Kayden Common Stock
Feb 11, 2024 Sell 2 031 Lee Jennifer Kayden Restricted Stock Units
Feb 11, 2024 Buy 1 562 Shulman Joseph Common Stock
Feb 11, 2024 Sell 1 562 Shulman Joseph Restricted Stock Units
Feb 09, 2024 Buy 4 063 Smith Hunter C Common Stock
Feb 09, 2024 Sell 4 063 Smith Hunter C Restricted Stock Units
Feb 09, 2024 Buy 3 438 Mazabraud Yann Common Stock
Feb 09, 2024 Sell 3 438 Mazabraud Yann Restricted Stock Units
Feb 09, 2024 Sell 3 438 Lee Jennifer Kayden Restricted Stock Units
Feb 09, 2024 Buy 3 438 Lee Jennifer Kayden Common Stock
Feb 09, 2024 Buy 69 190 Shulman Joseph Common Stock
Feb 09, 2024 Sell 100 Shulman Joseph Common Stock
Feb 09, 2024 Sell 48 177 Shulman Joseph Common Stock
Feb 09, 2024 Sell 69 190 Shulman Joseph Stock Option (right to buy)
Feb 09, 2024 Sell 2 656 Shulman Joseph Restricted Stock Units
Feb 09, 2024 Buy 2 656 Shulman Joseph Common Stock
Feb 09, 2024 Sell 23 397 Shulman Joseph Common Stock
Feb 09, 2024 Sell 100 Shulman Joseph Common Stock
Feb 09, 2024 Buy 2 344 Cramer Pamela J. Common Stock
Feb 09, 2024 Sell 2 344 Cramer Pamela J. Restricted Stock Units
Feb 01, 2024 Sell 4 513 Lee Jennifer Kayden Restricted Stock Units
Feb 01, 2024 Buy 4 513 Lee Jennifer Kayden Common Stock
Feb 01, 2024 Sell 1 492 Lee Jennifer Kayden Common Stock
Feb 01, 2024 Buy 4 925 Smith Hunter C Common Stock
Feb 01, 2024 Sell 1 616 Smith Hunter C Common Stock
Feb 01, 2024 Sell 4 925 Smith Hunter C Restricted Stock Units
Feb 01, 2024 Sell 3 938 Shulman Joseph Restricted Stock Units
Feb 01, 2024 Buy 3 938 Shulman Joseph Common Stock
Feb 01, 2024 Sell 1 324 Shulman Joseph Common Stock
Feb 01, 2024 Buy 14 125 Meeker David P Common Stock
Feb 01, 2024 Sell 4 361 Meeker David P Common Stock
Feb 01, 2024 Sell 14 125 Meeker David P Restricted Stock Units
Feb 01, 2024 Buy 2 650 Cramer Pamela J. Common Stock
Feb 01, 2024 Sell 946 Cramer Pamela J. Common Stock
Feb 01, 2024 Sell 2 650 Cramer Pamela J. Restricted Stock Units
Dec 29, 2023 Sell 10 500 Smith Hunter C Stock Option (Right to Buy)
Dec 29, 2023 Buy 10 500 Smith Hunter C Common Stock
Dec 28, 2023 Sell 6 800 Shulman Joseph Stock Option (Right to Buy)
Dec 28, 2023 Buy 6 800 Shulman Joseph Common Stock
Dec 28, 2023 Sell 7 926 Shulman Joseph Common Stock
Dec 27, 2023 Sell 2 400 Shulman Joseph Stock Option (Right to Buy)
Dec 27, 2023 Buy 2 400 Shulman Joseph Common Stock
Dec 27, 2023 Sell 5 015 Shulman Joseph Common Stock
Dec 06, 2023 Sell 20 000 Smith Hunter C Stock Option (Right to Buy)
Dec 06, 2023 Buy 20 000 Smith Hunter C Common Stock
Dec 06, 2023 Sell 20 000 Smith Hunter C Common Stock
Dec 05, 2023 Sell 7 026 Smith Hunter C Stock Option (Right to Buy)
Dec 05, 2023 Buy 7 026 Smith Hunter C Common Stock
Dec 05, 2023 Sell 7 026 Smith Hunter C Common Stock
Nov 24, 2023 Sell 10 974 Smith Hunter C Stock Option (Right to Buy)
Nov 24, 2023 Buy 10 974 Smith Hunter C Common Stock
INSIDER POWER
38.075
Last 100 transactions
Buy: 1 143 191 | Sell: 502 628 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 38.075.

In total, the insiders bought 1 143 191 and sold 502 628 RYTM shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström s... RYTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT